Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891189788> ?p ?o ?g. }
- W2891189788 endingPage "1704" @default.
- W2891189788 startingPage "1693" @default.
- W2891189788 abstract "Introduction: Actinic keratosis (AK) is a superficial squamous cell carcinoma (SCC) where chronic sun exposure playing central role in its pathogenesis. UVB causes direct damage to DNA, producing pyrimidine dimers, and suppressing the protective role of p53. The stepwise progression of AK, with increased expression of anti-apoptotic Bcl-2, favors progression to SCC. Moreover, the dermal response characterized by inflammation and mediated by prostaglandins is a critical component of tumorigenesis that promotes tumor growth, tissue invasion, angiogenesis and metastasis. Other risk factors are represented by age, gender, phototype and drugs.Areas covered: In this review, the authors document the recent developments of different therapies used to treat AK and provide their perspectives on current and future treatment strategies.Expert opinion: The usefulness of long-term treatment with piroxicam and sun filters or diclofenac targeting the inflammation phases of skin tumorigenesis favors AK’s healing and provides greater control of the cancerization field. Nonsteroidal anti-inflammatory drugs can be safely used in patients who use photosensitizing drugs and, therefore, are more at risk of developing skin tumors. Immunomodulatory therapies, which require shorter treatment, are characterized by more common local side effects, and need more attention by the dermatologist in the concern of patient education, resulting essential to improve adherence and outcomes." @default.
- W2891189788 created "2018-09-27" @default.
- W2891189788 creator A5004401304 @default.
- W2891189788 creator A5007226700 @default.
- W2891189788 creator A5028712141 @default.
- W2891189788 creator A5074308450 @default.
- W2891189788 creator A5077615450 @default.
- W2891189788 creator A5084285371 @default.
- W2891189788 creator A5086252442 @default.
- W2891189788 creator A5086793471 @default.
- W2891189788 date "2018-10-09" @default.
- W2891189788 modified "2023-09-25" @default.
- W2891189788 title "Current developments in pharmacotherapy for actinic keratosis" @default.
- W2891189788 cites W1518542525 @default.
- W2891189788 cites W1540044642 @default.
- W2891189788 cites W1825249855 @default.
- W2891189788 cites W1850345829 @default.
- W2891189788 cites W1883933571 @default.
- W2891189788 cites W1901798279 @default.
- W2891189788 cites W1911093385 @default.
- W2891189788 cites W1930410348 @default.
- W2891189788 cites W1932200564 @default.
- W2891189788 cites W1933854601 @default.
- W2891189788 cites W1963995562 @default.
- W2891189788 cites W1966198670 @default.
- W2891189788 cites W1968822041 @default.
- W2891189788 cites W1970641169 @default.
- W2891189788 cites W1972197499 @default.
- W2891189788 cites W1980313944 @default.
- W2891189788 cites W1985299393 @default.
- W2891189788 cites W1988910572 @default.
- W2891189788 cites W1991949008 @default.
- W2891189788 cites W1995629059 @default.
- W2891189788 cites W1997184970 @default.
- W2891189788 cites W2007413267 @default.
- W2891189788 cites W2015471056 @default.
- W2891189788 cites W2018738562 @default.
- W2891189788 cites W2025039194 @default.
- W2891189788 cites W2025917870 @default.
- W2891189788 cites W2026075298 @default.
- W2891189788 cites W2032308316 @default.
- W2891189788 cites W2035816846 @default.
- W2891189788 cites W2038956615 @default.
- W2891189788 cites W2039295712 @default.
- W2891189788 cites W2039773944 @default.
- W2891189788 cites W2040528315 @default.
- W2891189788 cites W2042176139 @default.
- W2891189788 cites W2045392965 @default.
- W2891189788 cites W2045966621 @default.
- W2891189788 cites W2046803819 @default.
- W2891189788 cites W2046897703 @default.
- W2891189788 cites W2057917620 @default.
- W2891189788 cites W2062266877 @default.
- W2891189788 cites W2063304334 @default.
- W2891189788 cites W2067575233 @default.
- W2891189788 cites W2068364493 @default.
- W2891189788 cites W2069247764 @default.
- W2891189788 cites W2071155002 @default.
- W2891189788 cites W2073874826 @default.
- W2891189788 cites W2089184013 @default.
- W2891189788 cites W2095364230 @default.
- W2891189788 cites W2095838337 @default.
- W2891189788 cites W2098885980 @default.
- W2891189788 cites W2105697859 @default.
- W2891189788 cites W2112205129 @default.
- W2891189788 cites W2112239594 @default.
- W2891189788 cites W2112873380 @default.
- W2891189788 cites W2113490865 @default.
- W2891189788 cites W2114562058 @default.
- W2891189788 cites W2116688544 @default.
- W2891189788 cites W2118917635 @default.
- W2891189788 cites W2119431839 @default.
- W2891189788 cites W2119623952 @default.
- W2891189788 cites W2119803906 @default.
- W2891189788 cites W2121308368 @default.
- W2891189788 cites W2121955821 @default.
- W2891189788 cites W2125476116 @default.
- W2891189788 cites W2129669702 @default.
- W2891189788 cites W2139099642 @default.
- W2891189788 cites W2140683149 @default.
- W2891189788 cites W2140716250 @default.
- W2891189788 cites W2143569023 @default.
- W2891189788 cites W2146763960 @default.
- W2891189788 cites W2152904612 @default.
- W2891189788 cites W2155272579 @default.
- W2891189788 cites W2168408099 @default.
- W2891189788 cites W2327499101 @default.
- W2891189788 cites W2490510536 @default.
- W2891189788 cites W2501524741 @default.
- W2891189788 cites W2545281701 @default.
- W2891189788 cites W2549672901 @default.
- W2891189788 cites W2557214320 @default.
- W2891189788 cites W2557774919 @default.
- W2891189788 cites W2577936807 @default.
- W2891189788 cites W2603570859 @default.
- W2891189788 cites W2736294381 @default.
- W2891189788 cites W2766795961 @default.
- W2891189788 cites W2769871690 @default.